← Every company
PTC Inc Patents
What PTC Inc has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
PTC on carbonthat →Filings on file
34
Granted
0
Still pending
34
Filed under
7 names
34 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| PHARMACEUTICALLY ACCEPTABLE SALTS OF SEPIAPTERINA61P 25/00, C07D 475/04, A61K 31/519, A61K 45/06, C07B2200/13, C07C 55/08, C07C 57/15, C07C 59/06, C07C 65/05, C07C 209/04, C07C 209/30, C07C 309/04, C07C 309/29, C07C 309/30, C07D 213/80Filed as PTC Therapeutics MP, Inc.2026-04-23Daniel E. LEVY | pending |
| CARBOLINE COMPOUNDS AND USE THEREOFC07D 471/04, A61K 31/437, A61K 31/506, A61K 31/53, A61K 31/5377Filed as PTC Therapeutics, Inc.2025-12-17Ramil BAIAZITOV | pending |
| METHODS FOR INCREASING VATIQUINONE PLASMA EXPOSURE WITH FOODA61K 31/122Filed as PTC THERAPEUTICS, INC.2025-12-12Lucy LEE | pending |
| HETEROCYCLIC AND HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASEC07D 487/04, A61P 25/14, A61P 25/28, C07D 491/048, C07D 495/04, C07D 519/00Filed as PTC Therapeutics HD, Inc.2025-11-20Nadiya SYDORENKO | pending |
| HETEROCYCLIC AND HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASEC07D 487/04, A61P 25/14, A61P 25/28, A61P 25/00, A61K 31/4985, A61K 31/5025, C07D 491/04, C07D 491/048, C07D 491/08, C07D 495/04, C07D 519/00Filed as PTC Therapeutics, Inc.2025-09-30Nadiya SYDORENKO | pending |
| COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHYC07D 519/00Filed as PTC Therapeutics, Inc.2025-08-29Hasane RATNI | pending |
| TREATMENT OF HUNTINGTONS DISEASEFiled as PTC THERAPEUTICS, INC.2025-06-11BRIAN MICHAEL BEERS | pending |
| METHODS FOR INCREASING SEPIAPTERIN PLASMA EXPOSUREA61P 25/00, A61K 31/519, A61P 3/00, A61K 9/0053Filed as PTC Therapeutics MP, Inc.2025-05-13Neil SMITH | pending |
| OXIDATIVE CLEAVAGE METHOD OF TROLOX AMIDEFiled as PTC Therapeutics, Inc.2025-03-19Hirotsugu USUTANI | pending |
| FORMULATIONS FOR STABILIZING DISSOLUTION OF MEDICAMENTSFiled as PTC THERAPEUTICS, INC.2025-03-13YOSHIHIRO ONOUE | pending |
| GRANULES FOR SUSPENSIONA61K 9/107, A61K 9/1641, A61K 31/16, A61K 9/0095, A61K 9/10, A61K 9/14, A61K 9/1623, A61K 9/1635, A61K 9/1652, A61K 47/02, A61K 47/10, A61K 47/14, A61K 47/26, A61K 47/32, A61K 47/34, A61K 47/36, A61K 47/38Filed as PTC THERAPEUTICS, INC.2025-03-11Kazuhiro HOKONOHARA | pending |
| COMPOSITIONS AND METHODS FOR INCREASING TETRAHYDROBIOPTERIN PLASMA EXPOSUREA61P 3/00, A61K 31/519, A61K 9/0065, A61K 31/4985Filed as PTC Therapeutics MP, Inc.2025-03-04Neil SMITH | pending |
| METHODS FOR MODULATING RNA SPLICINGA61K 31/4365, C12N 15/85Filed as PTC THERAPEUTICS, INC.2025-02-07Wencheng LI | pending |
| POLYMORPHS OF SEPIAPTERIN AND SALTS THEREOFC07D 475/04, A61P 15/10, A61P 7/02, A61P 3/08, A61P 9/10, A61P 43/00, A61P 1/16, A61P 3/00, A61P 25/22, A61P 9/12, A61P 13/02, A61P 13/12, A61P 25/18, A61P 25/24, A61P 25/00, A61P 25/16, A61K 31/519, C07B2200/07, C07B2200/13Filed as PTC Therapeutics MP, Inc.2025-01-15Daniel E. LEVY | pending |
| PHARMACEUTICAL COMPOSITIONS COMPRISING SEPIAPTERIN AND USES THEREOFA61K 9/0095, A61K 31/519, A61P 3/00, A61P 25/00, A61K 9/14, A61K 9/1617, A61K 9/20, A61K 38/40, A61K 47/22, A61K 47/38Filed as PTC Therapeutics MP, Inc.2024-12-20Daniel E. LEVY | pending |
| COMPOUNDS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3C07D 495/04, A61P 25/28, A61P 25/00, A61P 35/00, A61K 31/4365, A61K 31/444, A61K 31/4545, A61K 31/519, A61K 31/5377, A61K 31/55, C07B 59/002, C07D 471/04, C07D 487/04Filed as PTC THERAPEUTICS, INC.2024-12-20Michael A. ARNOLD | pending |
| HETEROCYCLIC AND HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASEC07D 487/04, A61P 25/14, A61P 25/28, A61K 31/4709, A61K 31/5025, A61K 31/517, C07D 471/04, C07D 519/00Filed as PTC THERAPEUTICS, INC.2024-12-03Ettore RASTELLI | pending |
| METHOD OF ELECTROLYTIC OXIDATIVE CLEAVAGE OF TROLOX AMIDEFiled as PTC THERAPEUTICS, INC.2024-11-28HIROTSUGU USUTANI | pending |
| INHIBITORS OF NLRP3C07D 487/04, A61P 37/00, A61P 25/28, A61P 29/00, A61K 31/53Filed as PTC THERAPEUTICS, INC.2024-08-16Xiaoyan ZHANG | pending |
| CARBOLINE COMPOUNDS AND USE THEREOFA61K 31/506, C07D 471/04, A61P 37/06, A61K 31/437, A61K 31/5377Filed as PTC Therapeutics, Inc.2024-06-28Ramil Baiazitov | pending |
| TREATMENT OF HUNTINGTONS DISEASEFiled as PTC THERAPEUTICS, INC.2024-06-20Amy-Lee BREDLAU | pending |
| METHODS FOR INCREASING VATIQUINONE PLASMA EXPOSUREFiled as PTC THERAPEUTICS, INC.2024-06-13LUCY LEE | pending |
| CARBOLINE COMPOUNDS AND USE THEREOFFiled as PTC THERAPEUTICS, INC.2024-05-16LIANG CAO | pending |
| Displaying Content in an Augmented Reality SystemG06T 19/006, G06T 7/75, G06F 3/011, G06F 3/0482, G06F 3/04842, G06T 15/06, G06T 15/20, G06T 19/20, G06T2200/24, G06T2207/10028, G06T2207/30244, G06T2219/2012Filed as PTC Inc.2024-05-03Stephen Prideaux-Ghee | pending |
| CRYSTALLINE FORMS OF 2-[3-(2,2,6,6-TETRAMETHYLPIPERIDIN-4-YL)-3H-[1,2,3]TRIAZOLO[4,5-C]PYRIDAZIN-6-YL]-5-(2H-1,2,3-TRIAZOL-2-YL)PHENOLFiled as PTC THERAPEUTICS HD, INC.2024-05-03LIANHE SHU | pending |
| ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMSA61K 31/167, C07C 233/29, A61P 23/02, A61K 31/4453, A61K 31/495, A61K 45/06, C07D 295/13Filed as PTC Innovations, LLC2024-04-02Dr. Pendleton Wickersham | pending |
| PHARMACEUTICAL COMPOSITION OF SEPIAPTERINA61K 31/519, A61K 9/009, A61K 9/1617, A61K 9/1623, A61K 9/1635, A61K 9/1652, A61K 9/1682Filed as PTC Therapeutics, Inc.2024-03-28Akm Nasir UDDIN | pending |
| METHODS FOR TREATING NEUROGENERATIVE DISEASESA61K 31/4365, A61K 31/444, A61K 31/497Filed as PTC THERAPEUTICS, INC.2024-03-06Scott J. Barraza | pending |
| METHODS FOR TREATING NEUROGENERATIVE DISEASESA61K 31/519, A61K 31/5355Filed as PTC THERAPEUTICS, INC.2024-03-06Scott J. Barraza | pending |
| METHODS FOR TREATING NEUROGENERATIVE DISEASESA61K 31/519Filed as PTC THERAPEUTICS, INC.2024-03-06Scott J. Barraza | pending |
| NOVEL RNA TRANSCRIPTC12N 15/113, C12N2310/11, C12N2320/33Filed as PTC THERAPEUTICS, INC.2024-02-23Anuradha BHATTACHARYYA | pending |
| HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASEC07D 487/04, A61P 25/14, A61P 25/28, A61K 31/5025Filed as PTC THERAPEUTICS, INC.2024-01-29Suresh BABU | pending |
| METHODS FOR SYNTHESIS OF RACEMIC, SCALEMIC, AND CHIRAL ALPHA-TOCOTRIENOL QUINONEC07D 309/10, C07C 50/28, C07D 303/04Filed as PTC Therapeutics, Inc.2024-01-29Peter GIANNOUSIS | pending |
| Simulation of Parts and Assemblies in a Computer Aided Design Modeling EnvironmentG06F 30/17, G06F 30/20Filed as PTC Inc.2024-01-25Christopher L. Gromek | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.
More on PTC
Company overviewEverything on PTC in one place, with the price.SEC filingsWhat PTC's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat PTC's own officers and directors buy and sell.Planned salesSales PTC insiders have filed notice of.Who owns itEvery manager reporting a position in PTC.Funds holding itWhich funds and ETFs hold PTC, and how big a bet.LobbyingWhat PTC spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on PTC's account, and who they worked for.Federal contractsWhat federal agencies pay PTC.